Tailored Review Proposal for Tuberculosis

Slides:



Advertisements
Similar presentations
Renewing Health Canada’s strategy against TB for First Nations on-reserve Provincial Primary Care Tuberculosis Education Day October 28, 2011 Presented.
Advertisements

Development Effectiveness in a world of targeted aid: the contribution of the Global Fund Dr. Viviana Mangiaterra Senior Coordinator, RMNCH and HSS Technical,
Technical Advisory Group meeting, WHO/WPRO
Global Plan to Stop TB Stop TB Partnership
DRC experience on joint TB HIV Concept Note Progress Update Jun 2014 Richard Mbumba Ngimbi, MD,MPH DRC WHO staff.
The World’s Biggest Minority Left Behind: National HIV-Responses Need to and Can Include Disability Towards a UNAIDS Disability Strategy Ruben Mayorga.
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
Concept Note development and modular tools
Concept Note on HIV Mongolia Process and key components of Funding Request to Global Fund.
Treatment Optimization in Latin America and the Caribbean: How can the GF contribute?
Teresa Guthrie M.PH (Health Economics) HIV modelling for in-country ownership solutions – generation of evidence IAS Conference, Washington DC, July.
Prioritized Areas and Process of R7 proposal GFATM Meeting on 12 April 2007.
Tajikistan The Global Fund to Fight AIDS, Tuberculosis and Malaria Support to the Strategic Plan to Prevent HIV/AIDS Epidemics in Tajikistan. November.
Downloaded from Accelerate scaling up of TB/HIV activities in Tanzania Dr. N.G.SIMKOKO WHO/NTLP - Tanzania.
Expert Consultation on Costing HIV Responses in Asia - Pacific October 2010 Recap of Day 1.
Overview of New Funding Model May 17, 2013 Astana, Kazakhstan.
WHO Expert Working Group on R&D Financing Stop TB New Tools Working Groups Marcos Espinal Executive Secretary.
Roadmap Progress Report 2011 Zambia SARN-RBM PARTNERS ANNUAL CONSULTATIVE MEETING, JULY 2011.
The Research and Development Goals of the Global Plan to Stop TB Marcos Espinal Executive Secretary.
U pdates on the development of the NTP National Strategic Plan GC National TB Conference Pokhara, July 14-15, 2014 Giampaolo Mezzabotta Medical.
Capacity Development – Haïti case study PMU May HAITI Program Management Unit Global Fund.
Session 11: MDR & XDR-TB: How Can Business Help Stem the Tide?
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
TFM Progress Update Malaria Tobgyel, Dy. Chief Programme Officer Vector-borne Disease Control 31st CCM meting, 28th August, 2015.
1 [INSERT SPEAKER NAME DATE & LOCATION HERE] Ethics of Tuberculosis Prevention, Care and Control MODULE 2: BACKGROUND ON TUBERCULOSIS Insert country/ministry.
December_2009 Partnership building. December_2009 Partnership building within the partnering process COREGROUPCOREGROUP FORMAL LAUNCH $ $ $ $ $ cost centre.
Securing the future today Synthesis of strategic information on HIV and young people Global Interagency Task Team on HIV and young people, June 2011.
15 step process for developing an inclusive and widely supported integrated RH/HIV Proposal R8 Richard Matikanya International HIV/AIDS Alliance.
Exploring financing options NATIONAL TB CONTROL OF VIETNAM.
Contribution of operational research in China National Center for TB Control and Prevention, China CDC Jiang Shiwen Cancun.
MDG 6: Combat HIV/AIDS and other diseases. Where are we…  Regionally, “on track” for MDG-6 (only a few countries are progressing slowly or show no progress)
PEPFAR The Global Fund and PEPFAR: Strategic Collaboration for Greater Impact Mark Edington, Director, Grants Management, Global Fund Julia Martin, Chief.
Dr Ral Antic Chair Scientific Committee IUATLD-APR Australia Pre-Conference Workshop 1 National TB Control Program Summary & Remarks.
United Republic of Tanzania Ministry of Health & Social Welfare MINISTRY OF HEALTH AND SOCIAL WELFARE NATIONAL AIDS CONTROL PROGRAM HIV CARE AND TREATMENT.
Global Fund Grant Proposal Round 11: Tuberculosis Nathan Furukawa Gabriella Boyle Rebekah Miner Paa Kobina Forson Xiaoxue Huang Hunter Pugh Gap Analysis.
THE GLOBAL FUND SUSTAINING THE GAINS AND IMPACT Uganda November 2013.
Tuberculosis - the opportunity in our lifetime Dr. Lucica Ditiu | Executive Secretary | Stop TB Partnership 09.April.2013 | Brussels, Belgium.
STRENGTHENING THE CAPACITY OF KEY POPULATIONS TO ENGAGE IN NATIONAL FUNDING PLATFORMS AND PROCESSES - TANZANIA CONTEXT ARASA PARTNERS FORUM 2015 PRESENTER;
Moving from a commodity approach: “Fund some of everything” or “Fund what is comfortable” to An Investment approach: “Fund evidenced-based activities.
CAMBODIA Application to the Global Fund New Funding Model Tom Hiatt Global TBTEAM meeting June 2014.
Outline The Global Fund Strategy emphasizes the Key Populations
An Overview of the Global Fund and its Architecture
Zimbabwe’s shift towards treat all: national country context
Bhutan CCM Structures: (Refection and challenges)
financial requirements
Incorporating transition considerations into the new Global Fund funding cycle Mauro Guarinieri Senior Technical Adviser, Community Responses and Drug.
Tailored Review Material Change-GF-Proposal
Access to Medicines for HIV/AIDS, Tuberculosis and Malaria.
Country Progress Report Cambodia
TB/HIV surveillance : Who is going to get the job done?
Progress: Bangladesh CCM GF SEA Constituency Meeting New Delhi, India
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Pre-conference Meeting Report
Building Health Systems to Deliver People-centered Health Services
Sunday, 22 July, 07:30-20:00 Room Elicium 1, RAI Amsterdam
Scale up of collaborative TB/HIV activities in Kenya
Proposal Development Overview by Proposal Development Committee
Sustainable Transition / Handover of malaria TB and HIV Global Fund Grants Generic 2018.
Knowledge gaps in formulating TB Control Policies for Prisons
World Tuberculosis Day 2016
Funding gaps to realize the Global Plan to End TB
Update on HIV and TB situation in SEAR Dr Mukta Sharma RA HIV TB HEP WHO SEARO Global Fund , South-East Asia Constituency Meeting, April 2018,
Update on Global Fund ATM
The STOP TB Strategy – 2009 VISION: A TB-free world
A Time of Commitments and Actions to accelerate action to End TB
ASAP support to the National HIV programme in Latvia Signe Rotberga Regional Coordinator for the Baltic States In Latvia, HIV.
OVERVIEW OF THE RNTCP GLOBAL FUND GRANT
TB-HIV/AIDS Co-Infection Coordination among Programs
The Global Fund Grants January 2018 to March 2021
How are programmes specifically designed using collected data?
Presentation transcript:

Tailored Review Proposal for Tuberculosis NTCP

Background for Material Change Bhutan is Gearing Towards Ending TB by 2035 National Guidelines for Management of TB/DR -TB guideline revised Moving towards treating latent TB infection JMM mission recommendations (2016)

Moving towards Active Case finding from Passive case finding Enhancing Infection Control Measures Targeted and focused intervention-More cases are concentrated in 8 districts- including districts bordering neighboring countries

High prevalence of MDR-TB-10% of all new TB cases, and 37% among retreatment cases. Expanded prevention and care to high-risk populations. Expand diagnosis and care for the treatment of RR-/MDR-TB as recommended by the WHO. WHO 2013 recording and reporting tools updated

Epidemiology Update

Estimate of TB Burden, 2015 MDGs achieved in 2015

Estimated Vs Notified

TB Case Notifications (2009-2016)

TB Case notification by Dzongkhags (2016) 993 cases in 8 districts accounting to 87% of the notified cases (Wangdi, S/jong, Sarpang, Chukha, Thimphu, Samtse, Mongar and Paro)

Estimated Vs. Notified

Notification of MDR-TB Cases: 2005-2016

Gearing towards TB Elimination by 2030 National Strategic Plan II (2017-2023) Gearing towards TB Elimination by 2030

Goal To reduce TB and DR-TB burden until it no longer poses a public health problem in Bhutan

Objectives To increase case notification rate of at least 90% among estimated TB and MDR-TB To maintain treatment success rate of at least 90% among Drug susceptible TB and 75% among MDR-TB To Improve TB/HIV co-infection case detection and ensure 100% registration To strengthen programmatic management of TB at all levels.  

Implementing Partners Grant Recipients Principal Recipient Ministry of Health Implementing Partners University of Medical Sciences of Bhutan

Modules and Interventions selected TB care and prevention Case detection and Diagnosis Treatment MDR-TB TB-HIV TB-HIV Collaborative interventions Resilient Sustainable Systems for Health (RSSH) Health Management information system and M& E

Targets The milestones for End TB strategy for 2030, the target year for the SDGs: To reach 90% of people who need treatment and treat them successfully by 2030 To reduce TB deaths by 90% by 2030 To reduce TB incidence by 80% by 2030 (less than 20 cases per 100,000 population)

Total Funding Need and Funding Request Total NSP is USD 9.68 Million (2017-2023) Total NSP Need for Funding cycle is USD 4.26 Million (2018-2021) Anticipated Domestic Resources- 2.54 Million Anticipated other resources-USD 30,000

National Strategic Plan(funding requirement ) Module Y1 Y2 Y3 Key AP 15500 MDR-TB-C&D 390300 124850 218650 MDR-TB-Treat 228050 176550 207710 Others 17500 RSSH 525214 478564 460214 TB care & prevention-C&D 263850 311578 242268 TB care & prevention-Treat 142900 88350 98400 TB-HIV 32600 88860 86800 Total 1615914 1301752 1347042

Anticipated Domestic Resources RGOB support 804,515 848,599 892,019 Module Y1 Y2 Y3 Key AP 8045 8486 8920 MDR-TB-C&D 120677 84860 89202 MDR-TB-Treat 201129 127290 133803 Others 16090 16972 17840 RSSH 254580 267606 TB care & prevention-C&D 241355 TB care & prevention-Treat 64361 67888 71362 TB-HIV 32181 33944 35681 Total

Financial Gap- for the funding cycle

Total Allocation for Tuberculosis 2019-2021 USD 1,074,146.00 (1.074Million)

Module wise budget forecast (%)

Module wise budget forecast

Sustainability Commitment from RGOB First Line TB Drugs procured through RGOB support Infrastructure and HR Bhutan Health Trust Fund mechanism

Proposal Development Process Sl Activity Date Remarks 1 35th CCM endorsed for Tailored Made Proposal 7th June 2017 Completed 2 Retreat to develop Zero drat proposal with TWG members 3rd -9th July 2017 3 Submitted Zero Draft to PDC,WHO and TWG members for comments 10/07/2017 4 Received comments from WHO, SEARO and GF 20/07/2017 and 21/07/17 5 Reviewed and Incorporated the comments from technical Experts 11/08/2017 6 Submitted the first draft to PDC, TWG and WHO 28/07/2017 7 17/08/2017 8 Submitted the 2nd Draft to PDC, TWGs, WHO and GF for further comments and feedbacks 18/08/2017 9 Received Comments and feedbacks from GF and WHO/PDC members 21/08/2017 10 Review of the comments Ongoing 11 Meeting with TWGS members to further review before the submission of proposal 24th August 2017 To be held 12 Online Submission 28th August 2017 Will be done

Thank you